OnQuality Pharmaceuticals Ltd.

We are dedicated to pioneering drug development to address specific side effects of cancer therapies, improve #quality-of-life of #cancer patients.

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

#MeetTheTeam Jie Luo, Ph.D., OnQuality’s Chief Scientific Officer and co-founder is an associate professor at Shanghai Jiao Tong University. She was involved in developing our propriety AI-enabled drug discovery platform (CARE).

Learn more about our team: https://t.co/dVh8nd7isl

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Researchers have developed an #AI model that could help doctors know when patients are likely to develop side effects so they can prescribe therapies such as the ones OnQuality is developing to prevent side effects before they develop.

https://t.co/iG8DqclSTK

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Wishing everyone a #HappyThanksgiving from OnQuality!

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

November is #NationalHealthSkinMonth. OnQuality is developing first-in-disease therapies in the emerging area of oncodermatology, or the management of skin toxicities caused by cancer therapies.

Learn more about our platforms: https://t.co/sZ4Iu9ipX3

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

November is #LungCancerAwarenessMonth. Lung cancer patients are commonly treated with anti-cancer agents that cause high rates of skin and GI-toxicities, which OnQuality is developing treatments for.

Learn more @LungAssociation:
https://t.co/al1MSF0n2b

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

OnQuality’s CEO, Mike McCullar, Ph.D., is guest-lecturing at @UOPacific’s ‘Design Thinking for Entrepreneurs', a course for scientists who want to transition into entrepreneurship.

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Our team presented data at the 34th EORTC-NCI-AACR symposium on our pre-clinical research for therapies to prevent chemotherapy-induced diarrhea and skin toxicity.

Read more about our research: https://t.co/T9x7RE0bmd

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

OnQuality’s CEO Mike McCullar, Ph.D., spoke at the Oncodermatology & Cutaneous Oncology Forum at the 2022 Fall Clinical Dermatology Conference.

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

We’re excited to announce we’ve enrolled the first patient in the second part of our Phase 2 NOVA-II trial for our lead compound OQL011, a treatment for VEGFR inhibitor-induced hand-foot skin reaction.

Read more here: https://t.co/AVYMZwDE3v

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Happy International #Podcast day! OnQuality’s leadership has been featured on a number of podcasts, including Conversations Life Sciences Leaders Aren’t Having with Jeff Harmon. Give it a listen if you haven’t gotten a chance to yet!

https://t.co/4pdRrpy87U

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

A survey of oncologists found that 98% would use a novel therapy to treat EGFR Inhibitor-induced skin toxicity. 77% report that they’ve interrupted #cancer #therapy because of severe skin toxicity.

Read more here: https://t.co/ftRzn4qjcp

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

A recent study found that doctors underestimate #cancer #therapy side effects and caregivers overestimate them, making appropriate treatment difficult.

Read here: https://t.co/Zj8U7urCpN

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

#Metastatic #BreastCancer is when cancer spreads from the breasts to other organs and tissues.

OnQuality is working hard to develop treatments for the side effects of cancer therapies.

Read more about our science here: https://t.co/sZ4Iu9iXMB

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

OnQuality is presenting preclinical data for two of our candidates at EORTC-NCI-AACR. Both therapies are designed as targeted supportive therapies to prevent the side effects of anti-cancer agents.

Read more about the posters: https://t.co/T9x7REhMdL

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

#Exercising can be really hard, especially when you’re feeling sick, but studies have shown that it can reduce the severity of the side effects of #cancer treatments.

Read here:
https://t.co/AT14KQgI1g

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

#ICYMI - OnQuality was featured in a wonderful @GENbio article from @AlexWestchester. In it, our CEO and CMO discuss the importance of cancer supportive therapies in detail.

Read here: https://t.co/AVhxXFD6Od

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

#BreastCancer is a terrible condition where certain side effects of the treatments can be just as bad as the disease

At OnQuality, we’re looking to change that by developing therapies to prevent and treat the side effects of cancer therapies

Read more:
https://t.co/RbkQ5tA7AC

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Treatments for thyroid #cancer can cause skin rashes, often so severe doctors have to stop treatment

We’re working on therapies for this and other side effects to improve the #qualityoflife for #thyroidcancer #patients

Learn more about thyroid cancer: https://t.co/9IAlcjpyFA

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

A recent study found that #cancer #patients may be genetically predisposed to adverse effects from #immunotherapies, which means it may be possible to predict patients’ reactions to therapies and to avoid treatments that trigger the worst #sideeffects

https://t.co/eaTiXVv9hb

[OnQuality Pharmaceuticals Ltd. @onquality_rx]

Currently, there are very few treatments available for #cancer #patients that suffer from immunotherapy-induced skin toxicities

OnQuality is working hard to fill this unmet need with therapies to treat this potentially serious condition

Read more here: https://t.co/sZ4Iu9ipX3